# FDA Inspection 818560 - Lonza AG - September 18, 2012

Source: https://www.keypedia.com/records/fda_inspections/lonza-ag/0bbb540e-edb5-4c8d-ae18-5c3d4de9a3cb
Source feed: FDA_Inspections

> FDA Inspection 818560 for Lonza AG on September 18, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 818560
- Company Name: Lonza AG
- Inspection Date: 2012-09-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1303682 - 2025-10-28](https://www.keypedia.com/records/fda_inspections/lonza-ag/78fcfce7-3d24-4ce5-9b7b-b09a46e71fee)
- [FDA Inspection 1279014 - 2025-04-04](https://www.keypedia.com/records/fda_inspections/lonza-ag/c8382a61-bc25-45cc-bf72-f8219f1cd14b)
- [FDA Inspection 1204183 - 2023-03-28](https://www.keypedia.com/records/fda_inspections/lonza-ag/87c8c9aa-762b-4daa-a90c-57b1f749b6c0)
- [FDA Inspection 1035618 - 2017-12-15](https://www.keypedia.com/records/fda_inspections/lonza-ag/6aabdbe9-cb78-4447-878b-509514b56a44)
- [FDA Inspection 967811 - 2016-03-11](https://www.keypedia.com/records/fda_inspections/lonza-ag/d3cf442a-abb3-4302-8fda-dc73abdabba3)

Company: https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
